Back to Market Feed

Product Information

TREMFYA 100 MG/ML SYRINGE is a brand product labeled by Janssen Biotech, Inc., priced at $14728.9053 per ML under NDC 57894064001. Its NADAC has been published 114 times since Jun 19, 2024.

TREMFYA 100 MG/ML SYRINGE

Guselkumab
$14728.9053per ML

Strength

100 mg/mL

NDC

57894064001

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

GUSELKUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761061

On Market Since

7/13/2017

Pharmacological Classes

Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price Statistics

The NADAC for TREMFYA 100 MG/ML SYRINGE has been published 114 times since Jun 19, 2024, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.

Current price$14728.9053 per ML
All-time high$14779.6320 (Jul 15, 2026)
All-time low$13347.2746 (Jul 17, 2024)
52-week high$14779.6320
52-week low$14066.4145
Median price$14029.9189
Average price$14025.6020
Largest weekly change+5.0% (Feb 5, 2025)
Weeks tracked114
Tracking sinceJun 19, 2024

Price History

1W

+0.1%

1M

-0.3%

3M

-0.3%

6M

-0.3%

1Y

+4.5%

3Y

N/A

5Y

N/A

All

+10.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

TREMFYA 100 MG/ML ONE-PRESS
Brand
57894064011•Janssen Biotech, Inc.
$14745.8421
+0% more

Related Drugs

Same classification

TREMFYA 200 MG/2 ML PEN
Brand
57894065102•Janssen Biotech, Inc.
$7318.9883
per ML
SKYRIZI 150 MG/ML PEN
Brand
00074210001•AbbVie Inc.
$22761.4629
per ML
SKYRIZI 150 MG/ML SYRINGE
Brand
00074105001•AbbVie Inc.
$22887.4386
per ML
STELARA 90 MG/ML SYRINGE
Brand
57894006103•Janssen Biotech, Inc.
$29792.7867
per ML
STELARA 45 MG/0.5 ML SYRINGE
Brand
57894006003•Janssen Biotech, Inc.
$29874.4480
per ML

Frequently asked questions

What is the NADAC price of TREMFYA 100 MG/ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for TREMFYA 100 MG/ML SYRINGE, manufactured by Janssen Biotech, Inc., is $14728.9053 per ML (NDC 57894064001), effective Aug 19, 2026.

How has the price of TREMFYA 100 MG/ML SYRINGE changed over time?

Over the history we have for it, the NADAC for TREMFYA 100 MG/ML SYRINGE has risen 10.1%. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.

What are the highest and lowest recorded NADAC prices for TREMFYA 100 MG/ML SYRINGE?

Since Jun 19, 2024, the NADAC for TREMFYA 100 MG/ML SYRINGE has ranged from a low of $13347.2746 (Jul 17, 2024) to a high of $14779.6320 (Jul 15, 2026), with a median of $14029.9189 per ML.

Are there cheaper alternatives to TREMFYA 100 MG/ML SYRINGE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TREMFYA 100 MG/ML SYRINGE in a comparable dosage form, but none are currently priced below it.

Who manufactures TREMFYA 100 MG/ML SYRINGE?

TREMFYA 100 MG/ML SYRINGE (NDC 57894064001) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.